Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 2.8% | n/a |
ROCE | 4.5% |
Latest | F'cast | |
---|---|---|
P/E | 8.8 | n/a |
PEG | 0.3 | n/a |
Pr/Revenue | 0.8 | n/a |
Pr/Book | 0.9 |
Latest | F'cast | |
---|---|---|
Revenue | 7.2% | n/a |
PBT | -27.7% | n/a |
EPS | 34.4% | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 83.70 | 2.90 | 31.40p | 13.6 | n/a | -20% | n/a | 0.0% |
31-Dec-21 | 94.30 | 8.20 | 39.70p | 12.7 | 0.5 | +26% | n/a | 0.0% |
31-Dec-22 | 97.70 | 0.20 | 13.60p | 20.6 | n/a | -66% | n/a | 0.0% |
31-Dec-23 | 114.20 | 4.70 | 26.20p | 9.9 | 0.1 | +93% | n/a | 0.0% |
31-Dec-24 | 122.40 | 3.40 | 35.20p | 16.1 | 0.5 | +34% | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Director/PDMR Shareholding | 02-Oct-2025 | 16:10 | RNS |
Holding(s) in Company | 30-Sep-2025 | 12:38 | RNS |
Directorate Changes | 23-Sep-2025 | 07:05 | RNS |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
30-Sep-25 | Buy | Clive Whiley | 320.00p | 25,000 | £80,000.00 |
Currency | UK Pounds |
Share Price | 295.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 586.00p |
52 Week Low | 270.00p |
Volume | 103,147 |
Shares Issued | 30.07m |
Market Cap | £88.72m |
Beta | 0.05 |
RiskGrade | 248 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 15-Sep-16 | 14-Apr-16 |
Paid | 13-Oct-16 | 11-May-16 |
Amount | 1.25p | 1.50p |
Time | Volume / Share Price |
15:31 | 28,942 @ 300.00p |
16:20 | 1 @ 300.00p |
16:19 | 3,397 @ 294.35p |
16:19 | 5,622 @ 291.10p |
15:57 | 2,150 @ 291.10p |
Chair | Andrew Kitchingman |
CEO | Adam Holland |
You are here: research